BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37860331)

  • 21. Retracted: Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
    Markers D
    Dis Markers; 2023; 2023():9841329. PubMed ID: 37538089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retracted: SNHG1/miR-145-5p/KLF5 Axis Participates in Regulating the Proliferation and Migration of Oral Squamous Cell Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9846372. PubMed ID: 37415882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
    International BR
    Biomed Res Int; 2022; 2022():9829634. PubMed ID: 36605105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retracted: Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway.
    International BR
    Biomed Res Int; 2024; 2024():9838254. PubMed ID: 38550170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retracted: The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9858395. PubMed ID: 38550122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retracted: circCNN2 Accelerates Cell Proliferation and Invasion in Lung Squamous Cell Carcinoma via Regulating miR-184/E2F1 and Activating MAPK Signaling Pathway.
    Markers D
    Dis Markers; 2023; 2023():9757632. PubMed ID: 37564088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
    Markers D
    Dis Markers; 2023; 2023():9836354. PubMed ID: 37744889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retracted: Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9795318. PubMed ID: 37565171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retracted: Diagnostic Value of MRI Combined with CXCR4 Expression Level in Lymph Node Metastasis Head and Neck Squamous Cell Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9754632. PubMed ID: 37538469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retracted: MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9876019. PubMed ID: 37475907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9851737. PubMed ID: 38549990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9879124. PubMed ID: 37502038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retracted: Knockdown of tumor protein D52-like 2 induces cell growth inhibition and apoptosis in oral squamous cell carcinoma.
    Cell Biol Int; 2016 Mar; 40(3):361. PubMed ID: 26909548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retracted: Risk Factor Analysis of Hepatic Encephalopathy and the Establishment of Diagnostic Model.
    International BR
    Biomed Res Int; 2023; 2023():9826704. PubMed ID: 38188793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retracted: Prognostic Value of Immunotyping Combined with Targeted Therapy in Patients with Non-Small-Cell Lung Cancer and Establishment of Nomogram Model.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9839714. PubMed ID: 37885866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retracted: Establishment of a Finite Element Model of Normal Nasal Bone and Analysis of Its Biomechanical Characteristics.
    International EM
    Emerg Med Int; 2023; 2023():9814568. PubMed ID: 38077110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retracted: Establishment of Difficult Caudal Epidural Blockade Prediction Model.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9845234. PubMed ID: 37501836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retracted: Establishment, Analysis, and Application of the Information Transmission and Response Model for Students of Vocational Colleges under Public Health Emergencies.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9759248. PubMed ID: 37946927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retracted: Establishment of a Risk Prediction Model for Pulmonary Infection in Patients with Advanced Cancer.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9802701. PubMed ID: 37621520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retracted: Establishment of a Survival Risk Prediction Model for Adolescent and Adult Osteosarcoma Patients.
    International BR
    Biomed Res Int; 2023; 2023():9851430. PubMed ID: 37829056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.